CoreRx’s expertise is formulation for B-OM and Evonik’s expertise is bulk production. There are different methods to change from liquid state to solid state. Not only you want the method with the highest yield, you also want to achieve it in the fewest steps (cheaper). Evonik can produce a large quality of liquid B for future trials such as B-ABSSSI Phase 3, B-UP oral/foam formulations and different dermatology indications.
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links